Weight loss results with Ozempic or other GLP-1 medications can vary based on factors like starting weight, lifestyle, medication dosage, and how the body responds
Patients who received GLP-1RAs were also associated with a significantly lower incidence of CVEs than individuals in the metformin and the second- or third-line glucose-lowering medications groups
For example, starting April 2026 , the Aetna Basic Control with ACSF plan will drop brand-name Saxenda in favor of generic Saxenda, aka liraglutide , and Zepbound
The long-term clinical significance is not yet established and is a specific focus of the ongoing phase 3 and cardiovascular follow-up program
Your GLP-1 Game Plan Starts Here Feeling a bit lost on your GLP-1 journey
Eli Lilly's TRIUMPH program includes trials covering obesity, cardiovascular disease, knee osteoarthritis, and long-term cardiovascular outcomes